On Monday (October 29) it was revealed which cannabis producers will invest in the retail plans of National Access Cannabis (TSXV:NAC).

Following an initial announcement of a subscription investment agreement deal from NAC last Tuesday (October 23), the company closed the first round of financing.


The full list of producers consists of established public players Aphria (TSX:APH), CannTrust Holdings (TSX:TRST), VIVO Cannabis (TSXV:VIVO) and upcoming public producer Zenabis.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

VIVO Cannabis was the first licensed producer to confirm its initial C$5 million investment with a possible extra C$5 million if NAC meets marked quotas attached to its retail plan last week.

Zenabis disclosed it signed up for up to C$15 million common shares of NAC with an initial C$5 million purchased during the first tranche, which closed last Friday (October 26).

Rick Brar, CEO of Zenabis, said his company sees this investment as a way to develop a relationship with a company looking to set up the “most widespread” retail network in Canada.

Zenabis is set to become a public producer by way of a reverse-takeover with Bevo Agro (TSXV:BVO) performed through Sun Pharm Investments.

The first tranche NAC announced provided the company with gross proceeds of C$20 million.

Mark Goliger, CEO of NAC, indicated the company expects to set up a footprint of over 200 cannabis retail shops in the next 18 months across five Canadian provinces.

In a statement to the Investing News Network (INN) Peter Aceto, CEO of CannTrust said NAC is “poised to transform the cannabis retail landscape.” Aceto added CannTrust will make available product the company’s adult-use brands to the eventual stores.

Details of investment transaction

The producers acquired stock of NAC at a price of C$0.91 per share. The total number of shares from the retail operator as part of the first tranche was approximately 22 million.

The second and third tranches of the investment deal are attached to specific goals: reaching 50 and 100 store approvals in Canada respectively.

The second and third tranches will close on October 26 in 2019 and 2020. However, NAC holds an option with all these producers to request the purchase of the subscribed stock agreed before the deadlines of the second and third tranches.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Adult-use cannabis became legal in Canada on October 17, allowing for the setup of physical retail shops, as per each province’s guidelines.

“We believe that the retail side of the industry has great potential and with our strong cash position, we chose to make another strategic investment in a leading cannabis retailer,” stated Barry Fishman, CEO of VIVO Cannabis.

NAC attracted attention to its retail play thanks to a deal with coffee retailer Second Cup (TSX:SCU) for a network of cannabis shops in Ontario.

Second Cup has even announced plans to retrofit existing coffee retail locations in favour of cannabis stores.

Investor takeaway

Shares of all the public cannabis producers in this deal took a sharp decline during Monday’s trading session.

At market closure on Monday,NAC shares dropped 1.23 percent reaching a price point of C$0.80. Aphria, CannTrust and VIVO took declines of 17.35, 15.43 and 8.57 percent on Monday.

Outside of a negative reaction to the investment deal, shares of cannabis companies have been taking a beating following Canadian legalization in what is seen as a sell off from investors.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Editor’s Note: This story was updated to include a statement from CannTrust. This story was updated to correct the name of Rick Brar, CEO of Zenabis.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less